Filter
3187
Filtered Results: 3187
Text search:
adverse
events
Featured
Recommendations
359
New Publications
750
Language
Document type
No document type
1579
Guidelines
566
Studies & Reports
545
Manuals
225
Strategic & Response Plan
110
Fact sheets
65
Training Material
49
Situation Updates
20
Infographics
10
Resource Platforms
6
Brochures
4
Online Courses
4
Videos
3
App
1
Countries / Regions
India
145
Global
131
Western and Central Europe
73
South Africa
73
Kenya
67
Ethiopia
59
Africa
47
Latin America and the Carribbean
47
Uganda
45
Nigeria
43
Ghana
40
Nepal
39
Tanzania
36
Bangladesh
36
Sierra Leone
33
Zambia
31
Myanmar / Burma
29
Philippines
28
Malawi
26
Eastern Europe
25
Liberia
25
Ukraine
23
South–East Asia Region
23
Rwanda
20
Namibia
19
Cambodia
18
Syria
17
Zimbabwe
15
Asia
13
Guinea
12
Eastern Europe and Central Asia
12
East and Southern Africa
12
Brazil
12
South Sudan
12
Lesotho
11
Colombia
10
Senegal
10
Mozambique
10
USA
10
Botswana
10
Indonesia
10
Congo, Democratic Republic of
9
Eswatini/ Swaziland
9
Haiti
8
Western Pacific Region
8
Chile
7
Venezuela
7
Germany
7
West and Central Africa
7
Russia
7
Thailand
6
Middle East and North Africa
6
Afghanistan
5
Moldova
5
Ecuador
5
Pakistan
5
Timor Leste/ East Timor
4
Cameroon
4
Laos
4
Burkina Faso
4
Jordan
4
Paraguay
4
Argentina
4
Lebanon
4
Sri Lanka
4
Yemen
4
Mali
4
Somalia
4
China
3
North America
3
Vietnam
3
Egypt
3
Sudan
3
Palestine
3
Angola
3
North Macedonia
2
Tajikistan
2
El Salvador
2
Kyrgyzstan
2
Niger
2
Bulgaria
2
United Kingdom
2
Belarus
2
Romania
2
Georgia
2
Central African Republic
2
Poland
2
Chad
2
Bhutan
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Fiji
1
Singapore
1
Burundi
1
Peru
1
Mauritania
1
Guinea-Bissau
1
Hungary
1
Lithuania
1
Ireland
1
Turkmenistan
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Djibouti
1
Slovakia
1
Honduras
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
922
Clinical Guidelines
387
Key Resources
204
Public Health
182
Women & Child Health
181
Capacity Building
54
Pharmacy & Technologies
37
Toolboxes
Mental Health
320
COVID-19
279
HIV
218
TB
210
Planetary Health
176
NTDs
105
Pharmacy
96
Caregiver
90
AMR
85
NCDs
71
Ebola & Marburg
65
Conflict
65
Global Health Education
59
Rapid Response
58
Disability
51
Malaria
49
Refugee
48
2.0 Rapid Response
39
Specific Hazards
35
Natural Hazards
35
Zika
24
Health Financing Toolbox
22
Polio
18
Cholera
14
Social Ethics
4
Typhoon
1
Biorisk reduction combines expertise and advice on high consequence pathogens with guidance and training on safe handling and control of disease agents that pose significant health risks, with potential for adverse economic impact and public concern.
Biorisk management includes analysis of ways a...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
Patient Safety is a health care discipline that emerged with the evolving complexity in health care systems and the resulting rise of patient harm in health care facilities. It aims to prevent and reduce risks, errors and harm that occur to patients during provision of health care. A cornerstone of ...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Interim Guidance, published 11 January 2021.
The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha...
The COVID-19 pandemic is having a profound negative effect on the global economy and is occurring in the context of a rapidly changing climate. This year is expected to be the second hottest in recorded history. Weather forecasts for 2020 indicate a high probability that extreme weather will adverse...
The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa.
The guidelines were developed by updating the Canadian ...
Malaria and HIV, two of the world’s most deadly diseases, are widespread, but their distribution overlaps greatly in sub-Saharan Africa. Consequently, malaria and HIV coinfection (MHC) is common in the region. In this paper, pertinent publications on the prevalence, impact, and treatment strategie...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
